What is the difference between activated and non‑activated platelet‑rich plasma (PRP) and when should each be used?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What Does PRP Activation Mean?

Activating PRP means triggering platelets to immediately release their growth factors from alpha-granules before injection, while non-activated PRP relies on the body's own tissues (like collagen) to trigger this release after injection. 1

The Biological Difference

Activated PRP

  • Immediate release mechanism: Platelets are stimulated externally (typically with thrombin, calcium chloride, or both) to degranulate and release bioactive proteins including VEGF, PDGF, and TGF-β before application 1, 2
  • Forms a fibrin clot: Creates a scaffold that captures secreted proteins and maintains their presence at the application site 1
  • Bolus delivery: All growth factors are released at once in high concentration 2

Non-Activated PRP

  • Delayed, physiologic release: Platelets remain intact until they encounter collagen-rich tissues at the injection site, which naturally triggers activation 1
  • Gradual release kinetics: Growth factors are released progressively over time as platelets interact with local tissue 2
  • No pre-formed clot: Remains in liquid form until injected 2

Common Activation Methods

The most frequently used activation agents include 1, 2:

  • Calcium chloride (CaCl₂): Induces progressive growth factor release over 24 hours
  • Thrombin: Produces immediate release with stable levels over time
  • Combination CaCl₂ + thrombin: Immediate release similar to thrombin alone
  • Collagen type I: Lower overall growth factor release, no clot formation

Clinical Decision-Making: When to Use Each

Use Activated PRP When:

  • Treating knee osteoarthritis: Meta-analysis demonstrates activated PRP provides significantly better pain relief (SMD -1.05) and functional improvement (SMD -1.21) compared to non-activated PRP 3
  • Immediate scaffold needed: Applications requiring fibrin matrix for structural support 1
  • Bone regeneration: Both activated and non-activated show comparable efficacy, but activation provides predictable release kinetics 4

Use Non-Activated PRP When:

  • Treating androgenetic alopecia: Non-activated PRP showed 31% greater increase in hair count and total hair density compared to activated PRP 5
  • Treating alopecia areata: No significant difference between activated and non-activated, making activation unnecessary 6
  • Collagen-rich tissue injection sites: The tissue itself will activate platelets naturally, eliminating need for pre-activation 1
  • Avoiding adverse effects: Non-activated PRP may have lower side effect profile in some applications 7

Critical Caveats

The evidence is contradictory and context-dependent. While activated PRP clearly outperforms non-activated for knee OA 3, the opposite is true for hair restoration 5. This reflects fundamental differences in tissue biology and healing mechanisms across anatomic sites.

Activation timing matters: The ISTH expert panel consensus rated it "uncertain" whether PRP must be activated before application (median score 5/9), acknowledging that collagen-rich tissues may eliminate the need for pre-activation 1

Preparation heterogeneity is rampant: The field suffers from poor standardization, with varying activation methods, durations, and timing all affecting clinical efficacy 1. Many trials fail to adequately define their PRP characteristics 1.

Practical Algorithm

  1. Identify the target tissue

    • Knee/joint cartilage → Use activated PRP 3
    • Scalp/hair follicles → Use non-activated PRP 5
    • Bone → Either acceptable, consider activated for predictable kinetics 4
  2. Assess tissue collagen content

    • High collagen (tendons, ligaments) → Non-activated acceptable, tissue will activate 1
    • Low collagen → Consider activated for controlled release
  3. Consider desired release kinetics

    • Immediate bolus needed → Thrombin or CaCl₂/thrombin activation 2
    • Sustained release preferred → CaCl₂ alone or non-activated 2

The choice between activated and non-activated PRP should be driven by the specific clinical indication and target tissue, not by arbitrary protocol preference.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.